Insmed Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $425.5M | $306.0M | $263.8M | $142.3M | $107.4M | $92.8M | $104.4M | $93.4M |
| Cost of Revenue | $67.2M | $47.4M | $44.2M | $29.4M | $28.1M | $21.3M | $26.2M | $21.2M |
| Gross Profit | $358.3M | $258.5M | $219.6M | $113.0M | $79.3M | $71.5M | $78.3M | $72.3M |
| Gross Margin | 84.2% | 84.5% | 83.2% | 79.4% | 73.9% | 77.1% | 75.0% | 77.3% |
| Operating Expenses | ||||||||
| Research & Development | $210.0M | $209.5M | $254.9M | $186.4M | $177.2M | $152.6M | $179.7M | $150.8M |
| SG&A Expense | $247.5M | $247.3M | $212.5M | $186.4M | $154.8M | $147.5M | $142.5M | $118.9M |
| Operating Income | $-1.5M | $-153.3M | $-319.7M | $-366.0M | $-312.9M | $-248.1M | $-230.4M | $-213.4M |
| Operating Margin | -0.4% | -50.1% | -121.2% | -257.1% | -291.3% | -267.3% | -220.6% | -228.4% |
| Interest Expense | — | — | — | — | $21.2M | $21.6M | $21.6M | $21.1M |
| Pretax Income | $-11.4M | $-162.1M | $-326.9M | $-368.7M | $-320.4M | $-255.7M | $-234.3M | $-219.5M |
| Income Tax Expense | $1.9M | $1.5M | $1.6M | $1.3M | $1.2M | $912.0K | $1.3M | $1.0M |
| Net Income | $-13.2M | $-163.6M | $-328.5M | $-370.0M | $-321.7M | $-256.6M | $-235.5M | $-220.5M |
| Net Margin | -3.1% | -53.5% | -124.5% | -260.0% | -299.5% | -276.4% | -225.5% | -236.0% |
| EPS (Basic) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 |
| EPS (Diluted) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 |
| Shares Outstanding (Basic) | 217.4M | 215.5M | 199.0M | 211.8M | 189.3M | 180.9M | 164.0M | 173.7M |
| Shares Outstanding (Diluted) | 217.4M | 215.5M | 199.0M | 211.8M | 189.3M | 180.9M | 164.0M | 173.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |